Therapeutic Advances in Drug Safety

Papers
(The H4-Index of Therapeutic Advances in Drug Safety is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS)62
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study53
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada32
Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana31
Semaglutide: a gendered phenomenon—women’s increased vulnerability to adverse drug reactions in the global weight loss trend24
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study21
Enhancing pharmacovigilance for robust drug safety monitoring: addressing underreporting and collaborative solutions20
Factors related to dosing frequency and route of administration in methotrexate intolerance among patients with rheumatoid arthritis: a cross-sectional study20
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community20
Methotrexate use and risk of abnormal alanine aminotransferase elevation in children with rare inflammatory diseases: a self-controlled case series analysis using a pediatric electronic health record 18
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database18
Incidence of antibody–drug conjugate-related hepatotoxicity in breast cancer: a systematic review and meta-analysis17
Corrigendum17
A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging17
Complex chronic adverse events following immunization: a systemic critique and reform proposal for vaccine pharmacovigilance16
Implementation of electronic distribution of Direct Healthcare Professional Communications by the Danish Medicines Agency: a survey study of physicians’ experiences and preferences15
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey15
0.099746942520142